Ask AI

From Smolder to Strategy: Optimizing Early Treatment Decisions in High-Risk SMM and NDMM

Downloadable slides featuring evidence for the need for accurate risk stratification, evidence for early intervention, and how to decide between treatment and observation in an individualized manner for patients with high-risk smoldering MM, as well as the optimal approaches for the selection of frontline therapy for patients who are newly diagnosed with active MM requiring treatment. Slides also include a synthesized version of the evolving treatment landscape, recommended guidelines, and ongoing clinical trials for patients with high-risk smoldering MM and those with newly diagnosed active MM.

Therapies for High Risk SMM and NDMM

Activity Information

Released: October 22, 2026